Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation

Volumn 30, Issue 11, 2002, Pages 785-792

  Epstein, J B ^a   Phillips, N ^a   Parry, J ^a   Epstein, M S ^a   Nevill, T ^a   Stevenson Moore, P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Olfaction; Oral complications of hematopoietic cell transplant; Oral function; Quality of life; Taste

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BENZYDAMINE; CHLORHEXIDINE; CYCLOSPORIN; GANCICLOVIR; HYDROMORPHONE; MORPHINE; NARCOTIC ANALGESIC AGENT; PREDNISONE; SODIUM CHLORIDE; TACROLIMUS;

ADULT; ALLOTRANSPLANTATION; ARTICLE; BITTER TASTE; CANCER CHEMOTHERAPY; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DRUG MEGADOSE; EMOTION; FATIGUE; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALE; MOUTH; MUCOSA INFLAMMATION; OUTCOMES RESEARCH; PATIENT CARE; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SEX DIFFERENCE; SMELLING; SOCIAL ASPECT; SWEETNESS; SYMPTOMATOLOGY; TASTE ACUITY; TASTE DISCRIMINATION; TIME; XEROSTOMIA;

ADULT; ANTINEOPLASTIC AGENTS; DATA COLLECTION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; OLFACTION DISORDERS; QUALITY OF LIFE; SEX FACTORS; TASTE DISORDERS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036903731     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703716     Document Type: Article

References (38)

1. Gotay CC, Moore TD. Assessing quality of life in head and neck cancer. Quality of Life Res 1992; 1: 5-17.
2. Sonis ST, Oster G, Fuchs H et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem cell transplantation. J Clin Oncol 2001; 19: 2201-2205.
3. Bellm LA, Epstein JB, Rose-Ped A et al. Patient reports of complications of bone marrow transplantation. Supp Care Cancer 2000; 8: 33-39.
4. Kopp M, Schweigkofler H, Holzner B et al. Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessment. Ann Hematol 1998; 77: 27-32.
5. Neithammer D, Mayer E. Long-term survivors: an overview on late effects, sequelae and second neoplasias. Bone Marrow Transplant 1998; 21 (Suppl. 2): S61-S63.
6. Badell I, Igual L, Gomez P et al. Quality of life in young adults having received a BMT during childhood: a GETMON study. Bone Marrow Transplant 1998; 21 (Suppl. 2): S68-S71.
7. Molassiotis A, Morris PJ. The meaning of quality of life and the effects of unrelated donor bone marrow transplants for chronic myeloid leukemia in adult long-term survivors. Cancer Nurs 1998; 21: 205-211.
8. Wingard JR. Quality of life following bone marrow transplantation. Curr Opin Oncol 1998; 10: 108-111.
9. Deeg HJ, Leisenring W, Storb R et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 1998; 91: 3637-3645.
10. Gotay CC, Muraoka MY. Quality of life in long-term survivors of adult-onset cancers. J Natl Cancer Inst 1998; 90: 656-667.
11. McQuellon RP, Russell GB, Rambo TD et al. Quality of life and psychological distress of bone marrow transplant recipients: The 'time trajectory' to recovery over the first year. Bone Marrow Transplant 1998; 21: 477-486.
12. Molassiotis A. A conceptual model of adaptation to illness and quality of life for cancer patients treated with bone marrow transplants. J Adv Nurs 1997; 26: 572-579.
13. Wettergren L, Languis A, Bjorkholm M, Bjorvell H. Physical and psychosocial functioning in patients undergoing autologous bone marrow transplantation - a prospective study. Bone Marrow Transplant 1997; 20: 497-502.
14. Chiodi S, Spinelli S, Ravera G et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 2000; 110: 614-619.
15. Mattsson T, Arvidson K, Heimdahl A et al. Alterations in taste acuity associated with allogeneic bone marrow transplantation. J Oral Pathol Med 1992; 21: 33-37.
16. Fernando IN, Patel T, Billingham L et al. The effect of head and neck irradiation on taste dysfunction: A prospective study. Clin Onc 1995; 7: 173-178.
17. Barale K, Aker SN, Martinsen CS. Primary taste thresholds in children with leukemia undergoing marrow transplantation. J Parent Ent Nutr 1982; 6: 287-290.
18. Bartoshuk LM. Chemosensory alterations and cancer therapies. NCI Monogr 1990; 9: 179-184.
19. Bernstein IL. Learned taste aversions in children receiving chemotherapy. Science 1978; 200: 1302-1303.
20. Seiden A (ed.). The initial assessment of patients with taste and smell disorders. In: Taste and Smell Disorders. Thieme: New York, 1997, pp 4-19.
21. Duffy V, Lucchina L, Fast K, Bartoshuk L. Taste and cancer. In: Berger A et al (eds). Principals and Practice of Supportive Oncology. Lippincott-Raven Publishers: Philadelphia, 1998, pp 141-151.
22. Holmes S. Food avoidance in patients undergoing cancer chemotherapy. Supp Care Cancer 1993; 1: 326-330.
23. Marinone MG, Rizzoni D, Ferremi P et al. Late taste disorders in bone marrow transplantation: clinical evaluation with taste solutions in autologous and allogeneic bone marrow recipients. Haematologica 1991; 76: 519-522.
24. Wickham RS, Rehwaldt M, Kefer C et al. Taste Changes Experienced by Patients Receiving Chemotherapy. ONF 1999; 26: 697-706.
25. Wickham RS, Rehwaldt M, Kefer C et al. Taste changes experienced by patients receiving chemotherapy. ONF 1999; 26: 697-705.
26. Bartoshuk L. Chemosensory alterations and cancer therapies. NCI Monogr 1990; 9: 179-184.
27. Mossman K, Shatzman A, Chencharick J. Long-term effects of radiotherapy on taste and salivary function in man. Int J Radiat Oncol Biol Phys 1982; 8: 991-997.
28. Epstein JB, Emerton S, Kolbinson D et al. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 1999; 21: 1-11.
29. Epstein JB, Robertson M, Emerton S et at. Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 2001; 23: 389-398.
30. Fernando L Patel T, Billingham L et al. The effect of head and neck irradiation on taste dysfunction: a prospective study. Clin Oncol 1995; 7: 173-178.
31. Abu-Hamdan D, Desai H, Sondheimer J et al. Taste acuity and zinc metabolism in captopril-treated hypertensive male patients. Am J Hypertens 1988; 1: 303S-308S.
32. Ruz S, Cavan K, Bettger W et al. Development of a dietary model for the study of mild zinc deficiency in humans and evaluation of biochemical and functional indices of zinc status. J Clin Nutr 1991; 53: 1295-1303.
33. Lindsey A, Piper B. Anorexia, serum zinc, and immunologic response in small cell lung cancer patients receiving chemotherapy and prophylactic cranial radiotherapy. Nutr Cancer 1986; 8: 231-238.
34. Ripamonti C, Zecca E, Brunelli C et al. A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer 1998; 82: 1938-1945.
35. Aaronson NK, Ahmedzai S, Bergman B et al, for the European Organization for Research and Treatment of Cancer, Study Group on Quality of Life. The EORTC QLQ-30: a quality of life instrument for the use in international trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
36. Fisher LD, Van Belle G. Biostatistics: A Methodology for the Health Sciences. John Wiley: New York, 1993, pp 631-647.
37. Sonis ST, Eilers JP, Epstein JB et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Cancer 1999; 85: 2103-2113.
38. Epstein JB, Stewart KH. Radiation therapy and pain in patients with head and neck cancer. Oral Oncol, Eur J Cancer 1993; 29B: 191-199.